• Press Release/Announcement
  • Published November 2018

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

This safety announcement raises awareness of pump failures, dosing errors, and other potential safety issues associated with implanted pumps. Recommendations to enhance safety include review of medication labeling to select appropriate medicines and concentrations as well as open discussions with patients about risks associated with pump and medication options.

Back to Top